139 related articles for article (PubMed ID: 28320150)
21. Association between EGF +61 G/A and glioma risk in a Chinese population.
Wang S; Zhao Y; Ruan Z; Chen H; Fan W; Chen J; Wu Q; Qian J; Zhang T; Huang Y; Lu D
BMC Cancer; 2010 May; 10():221. PubMed ID: 20487573
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility.
Zhao P; Zou P; Zhao L; Yan W; Kang C; Jiang T; You Y
BMC Cancer; 2013 May; 13():234. PubMed ID: 23663450
[TBL] [Abstract][Full Text] [Related]
23. Single nucleotide polymorphisms of matrix metallopeptidase 3 and risk of gliomas in a Chinese Han population.
Fan W; Zhou K; Hu D; Song X; Zhao Y; Chen H; Wei Q; Chen G; Shi J; Du G; Mao Y; Lu D; Zhou L
Mol Carcinog; 2012 Oct; 51 Suppl 1():E1-10. PubMed ID: 21853476
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants in SLC7A7 are associated with risk of glioma in a Chinese population.
Fan S; Zhao Y; Li X; Du Y; Wang J; Song X; Zhou F; Chen H; Chen G; Zhao Y; Mao Y; Lan Q
Exp Biol Med (Maywood); 2013 Sep; 238(9):1075-81. PubMed ID: 23975734
[TBL] [Abstract][Full Text] [Related]
25. CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population.
Wei XB; Jin TB; Li G; Geng TT; Zhang JY; Chen CP; Gao GD; Chen C; Gong YK
Asian Pac J Cancer Prev; 2014; 15(8):3629-33. PubMed ID: 24870769
[TBL] [Abstract][Full Text] [Related]
26. Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.
Zhang C; de Smith AJ; Smirnov IV; Wiencke JK; Wiemels JL; Witte JS; Walsh KM
J Neurooncol; 2017 Nov; 135(2):237-244. PubMed ID: 28721485
[TBL] [Abstract][Full Text] [Related]
27. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
Wang H; Burnett T; Kono S; Haiman CA; Iwasaki M; Wilkens LR; Loo LW; Van Den Berg D; Kolonel LN; Henderson BE; Keku TO; Sandler RS; Signorello LB; Blot WJ; Newcomb PA; Pande M; Amos CI; West DW; Bézieau S; Berndt SI; Zanke BW; Hsu L; ; Lindor NM; Haile RW; Hopper JL; Jenkins MA; Gallinger S; Casey G; ; Stenzel SL; Schumacher FR; Peters U; Gruber SB; ; Tsugane S; Stram DO; Le Marchand L
Nat Commun; 2014 Aug; 5():4613. PubMed ID: 25105248
[TBL] [Abstract][Full Text] [Related]
28. Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study.
Zhao P; Zhao L; Zou P; Lu A; Liu N; Yan W; Kang C; Fu Z; You Y; Jiang T
BMC Cancer; 2012 Dec; 12():617. PubMed ID: 23259684
[TBL] [Abstract][Full Text] [Related]
29. Impact of ANXA5 polymorphisms on glioma risk and patient prognosis.
Guo X; Song J; Zhao J; Wang B; Yang Z; Sun P; Hu M
J Neurooncol; 2019 Mar; 142(1):11-26. PubMed ID: 30536196
[TBL] [Abstract][Full Text] [Related]
30. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants in MIR17HG affect the susceptibility and prognosis of glioma in a Chinese Han population.
Feng J; Ouyang Y; Xu D; He Q; Liu D; Fan X; Xu P; Mo Y
BMC Cancer; 2020 Oct; 20(1):976. PubMed ID: 33036577
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
[TBL] [Abstract][Full Text] [Related]
33. Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Wu Y
BMC Neurol; 2019 Nov; 19(1):296. PubMed ID: 31759389
[TBL] [Abstract][Full Text] [Related]
34. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract][Full Text] [Related]
35. SPP1 promoter polymorphisms and glioma risk in a Chinese Han population.
Chen J; Wu Q; Lu Y; Xu T; Huang Y; Ribas J; Ni X; Hu G; Huang F; Zhou L; Lu D
J Hum Genet; 2010 Jul; 55(7):456-61. PubMed ID: 20505679
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Common Variants in the
Zhao T; Ma C; Xie B; Zhao B; Wang W; Liu J
Genet Test Mol Biomarkers; 2020 Jul; 24(7):425-430. PubMed ID: 32460535
[No Abstract] [Full Text] [Related]
37. Effect of OR51E1 single nucleotide polymorphisms on glioma susceptibility in the Chinese Han population.
Wei J; Zhang H; Ma X; Li Y; Zhou W; Guo J; Jin T; Hu M
Gene; 2023 Jul; 875():147489. PubMed ID: 37207826
[TBL] [Abstract][Full Text] [Related]
38. Assessing the association between EFEMP1 rs3791679 polymorphism and risk of glioma in a Chinese Han population.
Jiang N; Peng YP; Wang XY; Dou CW; He WM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706619
[TBL] [Abstract][Full Text] [Related]
39. Association between genetic polymorphisms of PTGS2 and glioma in a Chinese population.
Lin RP; Yao CY; Ren DX
Genet Mol Res; 2015 Apr; 14(2):3142-8. PubMed ID: 25966079
[TBL] [Abstract][Full Text] [Related]
40. Pleckstrin homology-like domain family B member 1 rs498872 polymorphism and glioma risk in Chinese Han population.
Zhang JW; Liu ZH; Lin XH; Du YP; Guo HT
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):7-9. PubMed ID: 28886307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
